No abstract available
MeSH terms
-
Anticoagulants / therapeutic use
-
Antifibrinolytic Agents / therapeutic use
-
Blood Loss, Surgical / prevention & control*
-
Cardiac Surgical Procedures / methods*
-
Coronary Artery Bypass / methods
-
Erythrocytes
-
Factor VIII / administration & dosage
-
Factor VIII / therapeutic use*
-
Heart Valve Prosthesis Implantation / methods
-
Hematocrit / methods
-
Hemophilia A / blood
-
Hemophilia A / surgery*
-
Heparin / therapeutic use
-
Heparin Antagonists / therapeutic use
-
Humans
-
Infusions, Intravenous / methods
-
Male
-
Middle Aged
-
Mitral Valve / surgery
-
Plasma
-
Platelet Count / methods
-
Postoperative Hemorrhage / prevention & control*
-
Protamines / therapeutic use
-
Time Factors
-
Tranexamic Acid / therapeutic use
Substances
-
Anticoagulants
-
Antifibrinolytic Agents
-
Heparin Antagonists
-
Protamines
-
Tranexamic Acid
-
Factor VIII
-
Heparin